Alzheimer's disease

News

Closeup of X-ray photography of human brain

Biogen tweaks confirmatory trial of Alzheimer's drug Aduhelm

Biogen and Eisai have expanded the size of the confirmatory trial of their Alzheimer's drug Aduhelm in order to "strengthen the data" for the drug.

News

Medicare limits Aduhelm coverage to clinical trial participa...

Biogen's difficult launch of controversial Alzheimer's therapy Aduhelm has been made even harder by a proposal by Medicare to cover the drug only for certain patients enrolled in clinical t

News

Biogen, Eisai Alzheimer's drug lecanemab fast tracked by FDA

Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer's programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up t

News

Biogen takes axe to Aduhelm price in a bid to drive take-up

Biogen has cut the list price of its Alzheimer's disease therapy in half from $56,000 to $28,200 a year, before the outcome of an ongoing reimbursement review of the drug by the US governme

News

Biogen's Alzheimer's drug Aduhelm is rejected by EU advisors

The EMA's human medicines committee has said it cannot approve Biogen and Eisai's Alzheimer's disease therapy Aduhelm, saying it was unconvinced by the data submitted for the drug.

News

Biogen updates on its confirmatory Aduhelm trial

Biogen and partner Eisai have said they will provide details next March for the confirmatory trial that will be needed to upgrade the drug's accelerated approval for controversial Alzheimer

Biogen tweaks confirmatory trial of Alzheimer's drug Aduhelm

Medicare limits Aduhelm coverage to clinical trial participa...

Biogen, Eisai Alzheimer's drug lecanemab fast tracked by FDA

Biogen takes axe to Aduhelm price in a bid to drive take-up

Biogen's Alzheimer's drug Aduhelm is rejected by EU advisors

Biogen updates on its confirmatory Aduhelm trial

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Alzheimer's disease

Editor's Picks